Myxedema coma risk factors: Difference between revisions
Jump to navigation
Jump to search
Aditya Ganti (talk | contribs) |
Aditya Ganti (talk | contribs) |
||
| Line 3: | Line 3: | ||
{{CMG}} ; {{AE}} {{ADG}} | {{CMG}} ; {{AE}} {{ADG}} | ||
==Overview== | ==Overview== | ||
Common risk factors in the development of myxedema coma include: | |||
==Risk factors== | ==Risk factors== | ||
Common risk factors in the development of myxedema coma include:<ref name="pmid6486153">{{cite journal |vauthors=Mazonson PD, Williams ML, Cantley LK, Dalldorf FG, Utiger RD, Foster JR |title=Myxedema coma during long-term amiodarone therapy |journal=Am. J. Med. |volume=77 |issue=4 |pages=751–4 |year=1984 |pmid=6486153 |doi= |url=}}</ref><ref name="pmid20454504">{{cite journal |vauthors=Kargili A, Turgut FH, Karakurt F, Kasapoglu B, Kanbay M, Akcay A |title=A forgotten but important risk factor for severe hyponatremia: myxedema coma |journal=Clinics (Sao Paulo) |volume=65 |issue=4 |pages=447–8 |year=2010 |pmid=20454504 |pmc=2862668 |doi=10.1590/S1807-59322010000400015 |url=}}</ref><ref name="pmid17712058">{{cite journal |vauthors=Kwaku MP, Burman KD |title=Myxedema coma |journal=J Intensive Care Med |volume=22 |issue=4 |pages=224–31 |year=2007 |pmid=17712058 |doi=10.1177/0885066607301361 |url=}}</ref> | Common risk factors in the development of myxedema coma include:<ref name="pmid6486153">{{cite journal |vauthors=Mazonson PD, Williams ML, Cantley LK, Dalldorf FG, Utiger RD, Foster JR |title=Myxedema coma during long-term amiodarone therapy |journal=Am. J. Med. |volume=77 |issue=4 |pages=751–4 |year=1984 |pmid=6486153 |doi= |url=}}</ref><ref name="pmid20454504">{{cite journal |vauthors=Kargili A, Turgut FH, Karakurt F, Kasapoglu B, Kanbay M, Akcay A |title=A forgotten but important risk factor for severe hyponatremia: myxedema coma |journal=Clinics (Sao Paulo) |volume=65 |issue=4 |pages=447–8 |year=2010 |pmid=20454504 |pmc=2862668 |doi=10.1590/S1807-59322010000400015 |url=}}</ref><ref name="pmid17712058">{{cite journal |vauthors=Kwaku MP, Burman KD |title=Myxedema coma |journal=J Intensive Care Med |volume=22 |issue=4 |pages=224–31 |year=2007 |pmid=17712058 |doi=10.1177/0885066607301361 |url=}}</ref> | ||
Revision as of 13:42, 25 September 2017
|
Myxedema coma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Myxedema coma risk factors On the Web |
|
American Roentgen Ray Society Images of Myxedema coma risk factors |
|
Risk calculators and risk factors for Myxedema coma risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2]
Overview
Common risk factors in the development of myxedema coma include:
Risk factors
Common risk factors in the development of myxedema coma include:[1][2][3]
- Hypothermia
- Cerebrovascular accidents
- Congestive heart failure
- Infections
- Drugs
- Gastrointestinal bleeding
- Trauma
- Metabolic disturbances
References
- ↑ Mazonson PD, Williams ML, Cantley LK, Dalldorf FG, Utiger RD, Foster JR (1984). "Myxedema coma during long-term amiodarone therapy". Am. J. Med. 77 (4): 751–4. PMID 6486153.
- ↑ Kargili A, Turgut FH, Karakurt F, Kasapoglu B, Kanbay M, Akcay A (2010). "A forgotten but important risk factor for severe hyponatremia: myxedema coma". Clinics (Sao Paulo). 65 (4): 447–8. doi:10.1590/S1807-59322010000400015. PMC 2862668. PMID 20454504.
- ↑ Kwaku MP, Burman KD (2007). "Myxedema coma". J Intensive Care Med. 22 (4): 224–31. doi:10.1177/0885066607301361. PMID 17712058.